Cambridge Innovation Capital

Microbiotica develops oral medicines made from selected live bacteria for inflammatory diseases and cancer treatment.

Salience Labs develops silicon photonic switches for datacenter operators connecting large AI computing clusters.

Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases

Provides AI-native security agents for autonomous systems

Provides a generative physics AI model for engineering teams